Skip to content

Drug interactions

Glecaprevir / pibrentasvir + Verapamil

Severity: Moderate

Glecaprevir / pibrentasvir and Verapamil: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both glecaprevir and pibrentasvir are P-gp substrates and inhibitors, and verapamil is also a P-gp inhibitor and substrate. Each may increase the other's exposure, with the main clinical concern being greater verapamil effect (hypotension, bradycardia).

What this interaction means in plain words

Glecaprevir / pibrentasvir and Verapamil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Mutual inhibition of P-glycoprotein efflux, with possible additional CYP3A4 effects.

What to do

Monitor blood pressure, heart rate and ECG during co-administration. Reduce the verapamil dose if excessive effects occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glecaprevir / pibrentasvir and Verapamil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Glecaprevir / pibrentasvir with Verapamil?

MediHelp rates the interaction as moderate. Glecaprevir / pibrentasvir and Verapamil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both glecaprevir and pibrentasvir are P-gp substrates and inhibitors, and verapamil is also a P-gp inhibitor and substrate. Each may increase the other's exposure, with the main clinical concern being greater verapamil effect (hypotension, bradycardia).

How serious is the interaction between Glecaprevir / pibrentasvir and Verapamil?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood pressure, heart rate and ECG during co-administration. Reduce the verapamil dose if excessive effects occur.

What other medicines interact with Verapamil?

MediHelp also lists interactions of Verapamil with, for example, Dofetilide, Flibanserin, Lomitapide. The full list is on the Verapamil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in